PFA

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-1.6%1-day move

₹0.61

prior close

₹0.61

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.0+0.0+0.0-1.6-1.6-1.6+0.0-1.6-1.6-1.6-1.6+0.0-6.6—

Up moveDown movePending

AI summary

Shree Ganesh Biotech (India) Ltd has filed a nil disclosure with BSE, Calcutta Stock Exchange, and Metropolitan Stock Exchange under SEBI Regulation 32(1). The company confirms that as of 31st March 2026, it does not have any funds remaining unutilised from proceeds of any public issue, rights issue, preferential issue, or qualified institutional placement (QIP) undertaken in the past. Since there are no unutilised funds, the company is not required to provide the standard Annexure-A format that details fund utilisation. This is a routine compliance filing confirming full deployment of any past capital raise proceeds.

Likely market impact

This is a routine regulatory confirmation with no direct impact on shareholders. The nil disclosure indicates the company has either not raised capital via these instruments or has fully utilised any such proceeds, with no deviation to report.